The Centers for Medicare and Medicaid Services wants to tap private sector expertise to help implement Medicare-negotiated “maximum fair prices” at the pharmacy counter beginning in 2026 for the 10 Part D drugs selected for the first round of negotiation, according to a request for information issued by the agency on 18 October.
Key Takeaways
-
The request for information explores how a private sector entity could handle the logistics of applying negotiated prices at the pharmacy counter.
-
CMS is interested in how to ensure prices go only to Medicare beneficiaries and do not duplicate 340B discounts
The RFI is intended to “research the availability and potential technical ability of healthcare-related organizations to provide … data exchange, customer support, as well as possible payment